Pulmoclear Clinical Research and Prescription Guidelines
Network
Join the Clear Thinking Community
Become a part of an exclusive network of respiratory specialists. Register to receive clinical updates, product insights, and professional resources directly from Fourrts.
Studies
Research &
Scientific
Studies
Curated clinical evidence supporting Pulmoclear's therapeutic efficacy in respiratory care.
Guidelines
Important Information
Review detailed prescribing information to ensure safe and effective administration of Pulmoclear for adult and geriatric patients.
Active Ingredients
Acebrophylline (100mg) + Acetylcysteine (600mg)
Indications
Treatment and management of COPD, Bronchiectasis, Chronic Bronchitis, Asthma, and other acute/chronic respiratory tract disorders associated with excessive mucus.
Dosage
Adults: One tablet twice daily, or as directed by the physician. Not recommended for children under 12 years.
Administration
To be taken orally, preferably after meals to minimize gastrointestinal discomfort.
Contraindications
Hypersensitivity to any component, severe hepatic/renal impairment, active peptic ulcer.
Adverse Effects
Mild GI upset, nausea, headache, dizziness (infrequent).